^
BRCA1 S451Lfs*20
Gallbladder Cancer
olaparib
Sensitive
:
C4
Onco Targets Ther - 2wk
No biomarker
Gallbladder Cancer
GC
Sensitive
:
A2
No biomarker
Gallbladder Cancer
GemOx
Sensitive
:
A2
No biomarker
Gallbladder Cancer
gemcitabine
Sensitive
:
A2
No biomarker
Gallbladder Cancer
GEM-CAP
Sensitive
:
A2
No biomarker
Gallbladder Cancer
CAPOX
Sensitive
:
A2
No biomarker
Gallbladder Cancer
XP
Sensitive
:
A2
No biomarker
Gallbladder Cancer
FP
Sensitive
:
A2
No biomarker
Gallbladder Cancer
capecitabine
Sensitive
:
A2
No biomarker
Gallbladder Cancer
5-fluorouracil
Sensitive
:
A2
No biomarker
Gallbladder Cancer
cisplatin + gemcitabine + albumin-bound paclitaxel
Sensitive
:
A2
No biomarker
Gallbladder Cancer
5-fluorouracil + oxaliplatin
Sensitive
:
A2
MSI-H/dMMR
Gallbladder Cancer
dostarlimab
Resistant
:
C1
HER-2 overexpression
Gallbladder Cancer
trastuzumab
Sensitive
:
C1
MSI-H/dMMR
Gallbladder Cancer
pembrolizumab
Sensitive
:
C1
MET amplification
Gallbladder Cancer
crizotinib
Sensitive
:
C3
ERBB3 mutation
Gallbladder Cancer
lapatinib
Sensitive
:
C3
HER-2 amplification
Gallbladder Cancer
trastuzumab
Sensitive
:
C3
HER-2 amplification
Gallbladder Cancer
lapatinib
Sensitive
:
C3
HER-2 amplification
Gallbladder Cancer
trastuzumab + lapatinib
Sensitive
:
C3
ERBB3 mutation
Gallbladder Cancer
trastuzumab
Sensitive
:
C3
ERBB3 amplification
Gallbladder Cancer
trastuzumab
Sensitive
:
C3
ERBB3 amplification + ERBB3 mutation
Gallbladder Cancer
trastuzumab
Sensitive
:
C3
FGFR3-TACC3 fusion
Gallbladder Cancer
Debio 1347
Sensitive
:
C3
BRAF L485W
Gallbladder Cancer
BVD-523
Sensitive
:
C3
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our